Table 3 Risks associated with the systolic home blood pressure at baseline and during follow-up in 3518 participants
Baseline | Follow-up | ||||
---|---|---|---|---|---|
End point (number) | Model | Hazard ratio (95% CI) | P-value | Hazard ratio (95% CI) | P-value |
Primary end point (51) | Adjusted | 1.57 (1.19–2.08) | 0.0015 | 1.60 (1.26–2.04) | 0.0002 |
Fully adjusted | 1.41 (1.06–1.89) | 0.019 | 1.47 (1.15–1.87) | 0.0020 | |
Fatal plus non-fatal end points | |||||
All cardiovascular (106) | Adjusted | 1.34 (1.11–1.62) | 0.0026 | 1.47 (1.23–1.75) | <0.0001 |
Fully adjusted | 1.21 (0.99–1.47) | 0.065 | 1.44 (1.21–1.72) | <0.0001 | |
Stroke (36) | Adjusted | 1.40 (1.01–1.95) | 0.046 | 1.59 (1.20–2.11) | 0.0011 |
Fully adjusted | 1.24 (0.88–1.76) | 0.22 | 1.53 (1.14–2.05) | 0.0046 | |
Ischemic heart disease (53) | Adjusted | 1.35 (1.03–1.76) | 0.029 | 1.37 (1.08–1.75) | 0.010 |
Fully adjusted | 1.25 (0.94–1.65) | 0.12 | 1.32 (1.04–1.69) | 0.026 | |
Myocardial infarction (12) | Adjusted | 1.75 (0.99–3.10) | 0.055 | 1.68 (1.05–2.69) | 0.030 |
Fully adjusted | 1.55 (0.84–2.83) | 0.16 | 1.57 (0.98–2.50) | 0.058 | |
Mortality | |||||
Total (58) | Adjusted | 1.04 (0.79–1.35) | 0.80 | 1.24 (0.99–1.57) | 0.067 |
Fully adjusted | 0.98 (0.75–1.29) | 0.90 | 1.25 (0.97–1.60) | 0.080 | |
Cardiovascular (8) | Adjusted | 2.33 (1.11–4.91) | 0.026 | 1.71 (0.89–3.28) | 0.11 |
Fully adjusted | 2.22 (1.03–4.80) | 0.041 | 1.46 (0.77–2.74) | 0.24 | |
Non-cardiovascular (50) | Adjusted | 0.91 (0.68–1.22) | 0.54 | 1.17 (0.91–1.52) | 0.22 |
Fully adjusted | 0.87 (0.64–1.17) | 0.36 | 1.22 (0.94–1.59) | 0.14 |